In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.

Published

Journal Article

The in vitro activities of tigecycline and selected antimicrobials were evaluated against a variety of multiple-drug-resistant clinical isolates, including extended-spectrum beta-lactamase- and/or metallo-beta-lactamase-producing gram-negative strains, colistin-resistant strains, vancomycin- and/or linezolid-resistant enterococci, and methicillin-resistant Staphylococcus aureus (MRSA). Tigecycline showed excellent activity against a collection of difficult-to-treat pathogens currently encountered in the hospital setting.

Full Text

Cited Authors

  • Souli, M; Kontopidou, FV; Koratzanis, E; Antoniadou, A; Giannitsioti, E; Evangelopoulou, P; Kannavaki, S; Giamarellou, H

Published Date

  • September 2006

Published In

Volume / Issue

  • 50 / 9

Start / End Page

  • 3166 - 3169

PubMed ID

  • 16940120

Pubmed Central ID

  • 16940120

Electronic International Standard Serial Number (EISSN)

  • 1098-6596

International Standard Serial Number (ISSN)

  • 0066-4804

Digital Object Identifier (DOI)

  • 10.1128/aac.00322-06

Language

  • eng